✦ LIBER ✦

Phase II study of dose-dense doxorubicin and docetaxel as neoadjuvant chemotherapy with G-CSF support in patients with large or locally advanced breast cancer

✍ Scribed by Jesús García-Mata; Andrés García-Palomo; Lourdes Calvo; Ramón Mel; Juan Jesús Cruz; Manuel Ramos

Publisher: Springer Milan
Year: 2008
Tongue: Spanish
Weight: 240 KB
Volume: 10
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-008-0280-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of neoadjuvant treatment

Phase II study of neoadjuvant treatment with doxorubicin, docetaxel, and capecitabine (ATX) in locally advanced or inflammatory breast cancer

✍ Gumersindo Pérez Manga; Parham Khosravi Shahi; Miguel Méndez Ureña; Rosa Quiben 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 214 KB

Phase II study of dose-dense sequential

Phase II study of dose-dense sequential doxorubicin and docetaxel for patients with advanced operable and inoperable breast cancer

✍ Brenda W. Cooper; Tomas Radivoyevitch; Beth A. Overmoyer; Robert R. Shenk; Huong 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 208 KB

Docetaxel plus epidoxorubicin as neoadju

Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast : A single-center, Phase II study

✍ Andrea de Matteis; Francesco Nuzzo; Giuseppe D'Aiuto; Vincenzo Labonia; Gabriell 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to test the activity and toxicity of epirubicin plus docetaxel as primary chemotherapy for women with large, operable (T2; > 3 cm) or locally advanced (Stage III) breast carcinoma, including patients with inflammatory breast carcinoma. ##

Epirubicin and paclitaxel with G-CSF sup

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy

✍ R. I. Lalisang; F. L. G. Erdkamp; C. J. Rodenburg; C. T. A. M. Knibbeler-van Ros 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 210 KB

A Multicenter Phase II Study of Docetaxe

A Multicenter Phase II Study of Docetaxel 60 mg/m2as First-Line Chemotherapy in Patients with Advanced or Recurrent Breast Cancer

✍ Takashi Ishikawa; Satoru Shimizu; Masaaki Inaba; Taro Asaga; Kiyohumi Katayama; 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 554 KB

Biweekly docetaxel and gemcitabine as ne

Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study

✍ L. G. Estévez; P. Sánchez-Rovira; M. Dómine; A. León; I. Calvo; A. Jaén; V. Casa 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 80 KB